ONCOC4
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment. OncoC4 was founded in 2020 and was headquartered in Rockville, Maryland.
ONCOC4
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.oncoc4.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
GlycoDesign
GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment.
Current Employees Featured
Official Site Inspections
http://www.oncoc4.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.49 K
- Host name: 172.67.193.79
- IP address: 172.67.193.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OncoC4"
About OncoC4 | Meet our world-class team of experts
Anchored by a team of business strategists and operations leaders with a proven history of getting products through clinical development, we are poised to offer patients battling evasive cancers …See details»
OncoC4 - Crunchbase Company Profile & Funding
Organization. OncoC4 . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... OncoC4 is a biopharmaceutical …See details»
OncoC4, Inc. - LinkedIn
OncoC4, Inc. | 1,820 followers on LinkedIn. Scientific Discoveries Drive Explosive Immunotherapy | Based in Rockville, Maryland, OncoC4 is a privately held, late clinical-stage …See details»
OncoC4 2025 Company Profile: Valuation, Funding
OncoC4 General Information Description. Operator of a biopharmaceutical company intended for the discovery of novel biologicals for cancer treatment. The company develops immunotherapy products targeting cancer evasion of …See details»
Christopher Mortko, PhD, MBA | OncoC4
Dr. Christopher Mortko is a Vice President and Head of Search and Evaluation in the Business Development and Licensing organization at Merck. In this role, Dr. Mortko leads a team responsible for the research, scientific evaluation, and …See details»
OncoC4, Inc. Company Profile | Rockville, MD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OncoC4, Inc. of Rockville, MD. Get the latest business insights from Dun & Bradstreet.See details»
OncoC4, Inc. Overview | SignalHire Company Profile
Based in Rockville, Maryland, OncoC4 is a privately held, late clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologics for the …See details»
OncoC4 - Contacts, Employees, Board Members, Advisors
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment. ... Log In. Experience the new Crunchbase, powered by AI . …See details»
OncoC4 - Recent News & Activity - Crunchbase
Oct 19, 2024 Organization. OncoC4 . Connect to CRM . Save . Go back to OncoC4's Signals & News . Recent News & Activity. Edit Recent News & Activity Section. Number of Articles 22. ...See details»
BioNTech and OncoC4 Announce Strategic Collaboration to Co …
Mar 20, 2023 BioNTech and OncoC4 will co-develop ONC-392 as monotherapy or in combination with anti-PD1 in various solid tumor indications, with a randomized Phase 3 trial …See details»
OncoC4 - VentureRadar
OncoC4 is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologicals for cancer treatment. OncoC4 is a spinout …See details»
OncoC4 Company Profile - Office Locations, Competitors, Revenue …
OncoC4 Summary. Company Summary. Overview. OncoC4 is a clinical-stage biopharmaceutical company that discovers and develops novel biologicals. It offers immunotherapy products for …See details»
Oncoc4 Company Profile | Management and Employees List
Oncoc4 Profile and History. OncoC4 develops first-in-class and best-in-class medicines for hard-to-treat cancers by leveraging CTLA-4, CD24, and siglecs. The company's therapies target …See details»
BioNTech, OncoC4 start late-stage lung cancer drug trial
Jun 29, 2023 BioNTech and its U.S. partner OncoC4 Inc say they have started a late-stage study of their lung cancer immunotherapy candidate as the German COVID-19 vaccine maker …See details»
Oncoc4 - Overview, News & Similar companies | ZoomInfo.com
In addition, OncoC4 has a pipeline of first-in-class preclinical products focusing on the CD24-Siglecs cancer immune evasion pathway. Read More. View Company Info for Free. Who is …See details»
OncoC4 Announces FDA Clearance of IND Application for …
Dec 2, 2024 About OncoC4. Based in Rockville, Maryland, OncoC4 is a privately held, late-stage biopharmaceutical company that is actively engaged in the discovery and development of …See details»
OncoC4 founders take own science under their wing in new …
Sep 25, 2024 OncoC4 is taking AcroImmune—and its in-house clinical manufacturing capabilities—under its wing in an all-stock merger. Both cancer biotechs were co-founded by …See details»
Senior Clinical Research Associate - Midwest | OncoC4
Minimum of 3 to 4 years of clinical monitoring and direct site management experience in a bio/pharma/ Clinical Research Organization; Experience monitoring oncology trials is required; …See details»
Helen F. Schiltz, MS, PhD | OncoC4
Prior to joining OncoC4 and OncoImmune, Dr. Schiltz was Senior Director of research and development at the Sabin Vaccine Institute. Before joining NIAID, she held manager and …See details»